Large animal models and gene therapy

被引:108
作者
Casal, M [1 ]
Haskins, M [1 ]
机构
[1] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA
关键词
animal models; gene therapy; viral vectors;
D O I
10.1038/sj.ejhg.5201535
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Over the last two decades, gene transfer experiments for the treatment of inherited or acquired diseases have mainly been performed in mice. While mice provide proof of principle and allow testing of a variety of therapeutic modalities, mouse models have some limitations, as only short-term experiments can be performed, their homogenous genetic background is unlike humans, and the knockout models do not always faithfully represent the human disease. Naturally occurring large animal models of human genetic diseases have become increasingly important despite the costs and the extensive clinical attention they require because of their similarities to human patients. Large animals are reasonably outbred, long lived allowing for longitudinal studies, are more similar in size to a neonate or small child providing an opportunity to address issues related to scaling up therapy, and many physiological parameters including the immune system are more similar to those in humans versus those in mice.
引用
收藏
页码:266 / 272
页数:7
相关论文
共 83 条
  • [61] Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases
    Phaneuf, D
    Wakamatsu, N
    Huang, JQ
    Borowski, A
    Peterson, AC
    Fortunato, SR
    Ritter, G
    Igdoura, SA
    Morales, CR
    Benoit, G
    Akerman, BR
    Leclerc, D
    Hanai, N
    Marth, JD
    Trasler, JM
    Gravel, RA
    [J]. HUMAN MOLECULAR GENETICS, 1996, 5 (01) : 1 - 14
  • [62] Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs
    Ponder, KP
    Melniczek, JR
    Xu, LF
    Weil, MA
    O'Malley, TM
    O'Donnell, PA
    Knox, VW
    Aguirre, GD
    Mazrier, H
    Ellinwood, NM
    Sleeper, M
    Maguire, AM
    Volk, SW
    Mango, RL
    Zweigle, J
    Wolfe, JH
    Haskins, ME
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (20) : 13102 - 13107
  • [63] The sheep model of in utero gene therapy
    Porada, CD
    Park, P
    Almeida-Porada, G
    Zanjani, ED
    [J]. FETAL DIAGNOSIS AND THERAPY, 2004, 19 (01) : 23 - 30
  • [64] QuintinColonna F, 1996, GENE THER, V3, P1104
  • [65] Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
    Raper, SE
    Chirmule, N
    Lee, FS
    Wivel, NA
    Bagg, A
    Gao, GP
    Wilson, JM
    Batshaw, ML
    [J]. MOLECULAR GENETICS AND METABOLISM, 2003, 80 (1-2) : 148 - 158
  • [66] Cloning of the canine β-glucuronidase cDNA, mutation identification in canine MPS VII, and retroviral vector-mediated correction of MPS VII cells
    Ray, J
    Bouvet, A
    DeSanto, C
    Fyfe, JC
    Xu, DB
    Wolfe, JH
    Aguirre, GD
    Patterson, DF
    Haskins, ME
    Henthorn, PS
    [J]. GENOMICS, 1998, 48 (02) : 248 - 253
  • [67] Gene therapy for arthritis
    Robbins, PD
    Evans, CH
    Chernajovsky, Y
    [J]. GENE THERAPY, 2003, 10 (10) : 902 - 911
  • [68] A SINGLE-BASE-PAIR DELETION IN THE BETA-GLUCURONIDASE GENE ACCOUNTS FOR THE PHENOTYPE OF MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII
    SANDS, MS
    BIRKENMEIER, EH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) : 6567 - 6571
  • [70] Mucopolysaccharidosis VII in a cat
    Schultheiss, PC
    Gardner, SA
    Owens, JM
    Wenger, DA
    Thrall, MA
    [J]. VETERINARY PATHOLOGY, 2000, 37 (05) : 502 - 505